Welcome to the first issue of Capsid & Tail, a mini-periodical of links, topics, and commentary that covers the ins and outs of the phage world.
This first issue covers Dr. Steffanie Strathdee’s path to treating her husband, Dr. Tom Patterson, with phages—one of the first major phage therapy successes in the US in decades. This led to the creation of the Center for Innovative Phage Applications and Therapeutics, or IPATH, the first phage therapy center in North America.
Pherecydes published the long-awaited results of PhagoBurn, the first blinded, controlled, randomized phage trial on burn patients.
AmpliPhi just received positive FDA feedback for phase 2 clinical trials using their phage cocktails against Pseudomonas aeruginosa(AB-PA01) and Staphylococcus aureus(AB-SA01).
Steffanie Strathdee and Urmi S. Bajpai announced a new 12-month postdoc position starting July 2019. The postdoc will work on phages in Dr. Bajpai’s lab at ANDC in Delhi. Contact [email protected] to apply (fellowship application deadline is November 15, 2018).
Phage Futures (January 29-30, 2019) is a translational phage therapy conference where Steffanie Strathdee, Tom Patterson, the FDA, and others will discuss how we move phage therapy forward in the US. Registration is open to all - use code “PHDI10” for 10% off. We’ll also be there!
One of these people was Tom Patterson, who suffered a case from antibiotic-resistant Acinetobacter baumanii, which he caught from a vacation trip to Egypt. Luckily for him, his wife is the associate dean of global health sciences, and an unstoppable force of nature, and was able to save his life by gathering a crack team of doctors and researchers in the nick of time.
For every issue of Capsid & Tail, we are committed to getting our facts straight, but we’re not experts in the information we’re bringing to you. If you feel that we’ve missed an important viewpoint, or if you have something to add, please reach out to us by emailing [email protected]. We’d love to hear from you, and we’d be happy to revisit topics we’ve covered (ideally with added information and viewpoints from community members like you!).
Lastly, please reach out if you’re interested in writing for us, or have suggestions for future issues!
Stay updated on phage research, phage therapy, and phage jobs by getting Capsid & Tail every week!
Have an idea for Capsid & Tail? Itching to promote your research? Excited to share about your new clinical trial or phage company news? Write for us!
Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.
We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.